M
MobiDrop
Single-cell sequencing and digital PCR instruments, kits and software for life-science research and diagnostics
About MobiDrop
MobiDrop is a biotechnology company founded in 2018 that develops microfluidics-based instruments, consumables and software for single-cell analysis and molecular diagnostics. Its core technology, droplet microfluidics, was developed with researchers at Harvard University, and the founding team includes alumni of Harvard and the Wyss Institute.
Products include the MobiNova-100 single-cell sequencing system, the MobiNova-M1 microbial single-cell genome sequencing system, MobiCube single-cell kits, MobiChIP kits and MobiVision bioinformatics software. These serve cancer research, immunology, microbiology and plant research, providing high-throughput single-cell multi-omics analysis and digital PCR workflows at lower cost than established alternatives.
MobiDrop operates R&D and production headquarters in Tongxiang, Jiaxing, Zhejiang, China, with a global innovation and business development center in Cambridge, Massachusetts, and an innovation center in Shanghai. It sells to academic laboratories, biotechnology companies and clinical research organizations and has obtained NMPA medical-device certification for part of its product line.
The company is building AI-ready life-science data infrastructure, partnering with NVIDIA's Inception program and Insilico Medicine on multi-omics data solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Jiaxing, China
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 54.8/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jul 2022 | $14M | $55M | Source Code Capital · Yunxiang Fund · LYFE Capital | ↗ |
| SPINOUT✓Other financing | May 2018 | $0 | — | Harvard University | — |
Growth signals
Latest recorded traffic for MobiDrop is 80 monthly website visits. MobiDrop's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
LYFE Capital
Source Code Capital- YFYunxiang Fund
Other known investors1 additional known investor
Harvard University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MobiDrop on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MobiDrop’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.